<?xml version="1.0" encoding="UTF-8"?>
<p>Jeyasri et al. used a system pharmacology approach to develop a strategy for multi-target treatment based on traditional Ayurvedic medicine, 
 <italic>Bacopa monnieri</italic>, for neurological diseases, focusing on Alzheimerâ€™s disease (AD) and Spinocerebellar ataxia (SCA) [
 <xref rid="B5-biomolecules-10-00936" ref-type="bibr">5</xref>]. When compared with commercially available drugs, it was revealed that the constituents of 
 <italic>Bacopa monnieri</italic> have asiatic acid and loliolide for treating AD and SCA. In addition, various potential actions from the bioactive compounds were predicted, particularly benefiting cognitive function.
</p>
